Ractigen Therapeutics is a clinical stage biotech company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery known as RNA activation (RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need.
| Website | http://www.ractigen.com |
| Revenue | $4 million |
| Employees | 19 (11 on RocketReach) |
| Founded | 2017 |
| Address | 金谷路99号, 苏州工业园区生物医药产业园三期 B 区 1 号楼四层, Suzhou, Jiangsu, CN |
| Phone | +86 513 8199 6959 |
| Technologies |
HTML
,
Bootstrap
,
jQuery
+2 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceutical, Manufacturing, Health Care |
| Keywords | Gene Therapy, Clinical Stage Biotech, Biotechnology, Cell Therapy, Drug Development, Novel Therapies, Genetic Diseases, Biopharma, Clinical Trials, Rare Diseases, Pharmaceutical, Oncology, Immunology |
| Competitors | Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Genentech, Moderna Therapeutics, Novavax, CureVac +45 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Ractigen Therapeutics employee's phone or email?
Ractigen Therapeutics Questions
The Ractigen Therapeutics annual revenue was $4 million in 2026.
Long-Cheng Li is the Co-founder, President and CEO of Ractigen Therapeutics.
11 people are employed at Ractigen Therapeutics.
Ractigen Therapeutics is based in Suzhou, Jiangsu.
The NAICS codes for Ractigen Therapeutics are [3254, 32541, 32, 325].
The SIC codes for Ractigen Therapeutics are [28, 283].
Top Ractigen Therapeutics Employees
-
11
-
Fei Zhu
VP at Ractigen Therapeutics
Beijing, China1 -
Jichao He
Associate Director, R and D at Ractigen Therapeutics
Wuxi, Jiangsu, CN -
Dunyang Yu
Senior HR Director at Ractigen Therapeutics
Wuhan, Hubei, CN1 -
1
